Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Cambridge Cognition Holdings ( (GB:COG) ) is now available.
Cambridge Cognition Holdings has published its Annual Report and Accounts for the year ended 31 December 2025, along with the notice of its upcoming Annual General Meeting, on the company’s website, with hard copies sent to shareholders who requested them. The AGM will be held on 21 May 2026 at the company’s registered office in Bottisham, Cambridge, providing investors and stakeholders an opportunity to review performance, governance and strategy as the group continues to build its global brand in digital brain health assessment.
Spark’s Take on COG Stock
According to Spark, TipRanks’ AI Analyst, COG is a Neutral.
The score is primarily held back by weak financial performance driven by ongoing losses and continued negative free cash flow, despite improving cash burn and a strengthened balance sheet. Technical indicators are neutral and do not add strong support, while valuation is constrained by a negative P/E and no dividend data.
To see Spark’s full report on COG stock, click here.
More about Cambridge Cognition Holdings
Cambridge Cognition Holdings is a neuroscience technology company that develops digital cognitive assessment tools used to drive scientific discovery, accelerate drug development and improve patient care. Its scalable, data-driven platforms target four main markets: clinical pharmaceutical studies, academic CNS research, healthcare diagnostics for physicians, and consumer health and wellness applications focused on brain health.
Average Trading Volume: 34,952
Technical Sentiment Signal: Sell
Current Market Cap: £16.99M
See more data about COG stock on TipRanks’ Stock Analysis page.